BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22879884)

  • 41. Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.
    Méndez-Lagares G; Pozo-Balado MM; Genebat M; García Pergañeda A; Leal M; Pacheco YM
    J Infect Dis; 2012 May; 205(10):1501-9. PubMed ID: 22457273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In untreated HIV-1-infected children, PBMC-associated HIV DNA levels and cell-free HIV RNA levels are correlated to distinct T-lymphocyte populations.
    Scott-Algara D; Rouzioux C; Blanche S; Burgard M; Didier C; Rivière Y; Buseyne F
    J Acquir Immune Defic Syndr; 2010 Apr; 53(5):553-63. PubMed ID: 20142750
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Study of CD4+CD8+ double positive T-lymphocyte phenotype and function in Indian patients infected with HIV-1.
    Chauhan NK; Vajpayee M; Mojumdar K; Singh R; Singh A
    J Med Virol; 2012 Jun; 84(6):845-56. PubMed ID: 22499005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children.
    Resino S; Galán I; Bellón JM; Navarro ML; León JA; Muñoz-Fernandez MA
    J Clin Immunol; 2003 Jul; 23(4):279-89. PubMed ID: 12959220
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of long-term infection with nef-defective attenuated HIV type 1 on CD4+ and CD8+ T lymphocytes: increased CD45RO+CD4+ T lymphocytes and limited activation of CD8+ T lymphocytes.
    Zaunders JJ; Geczy AF; Dyer WB; McIntyre LB; Cooley MA; Ashton LJ; Raynes-Greenow CH; Learmont J; Cooper DA; Sullivan JS
    AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1519-27. PubMed ID: 10580402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy.
    Cossarizza A; Bertoncelli L; Nemes E; Lugli E; Pinti M; Nasi M; De Biasi S; Gibellini L; Montagna JP; Vecchia M; Manzini L; Meschiari M; Borghi V; Guaraldi G; Mussini C
    PLoS One; 2012; 7(12):e50728. PubMed ID: 23236388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frequency of human endogenous retroviral sequences (HERV) K113 and K115 in the Polish population, and their effect on HIV infection.
    Zwolińska K; Knysz B; Gąsiorowski J; Pazgan-Simon M; Gładysz A; Sobczyński M; Piasecki E
    PLoS One; 2013; 8(10):e77820. PubMed ID: 24204983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intracellular HIV-1 RNA and CD4+ T-cell activation in patients starting antiretrovirals.
    El-Diwany R; Breitwieser FP; Soliman M; Skaist AM; Srikrishna G; Blankson JN; Ray SC; Wheelan SJ; Thomas DL; Balagopal A
    AIDS; 2017 Jun; 31(10):1405-1414. PubMed ID: 28358734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection.
    Michaud HA; de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF
    Retrovirology; 2014 Jan; 11():10. PubMed ID: 24472118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of T cell activation, HIV replication and hepatitis C virus infection on neutrophil CD64 expression.
    Morquin D; Tuaillon E; Makinson A; Bendriss S; Le Moing V; Reynes J
    Cytometry B Clin Cytom; 2017 Nov; 92(6):492-497. PubMed ID: 27221825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 Tat protein.
    Gonzalez-Hernandez MJ; Cavalcoli JD; Sartor MA; Contreras-Galindo R; Meng F; Dai M; Dube D; Saha AK; Gitlin SD; Omenn GS; Kaplan MH; Markovitz DM
    J Virol; 2014 Aug; 88(16):8924-35. PubMed ID: 24872592
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma.
    Rakoff-Nahoum S; Kuebler PJ; Heymann JJ; E Sheehy M; Ortiz GM; S Ogg G; Barbour JD; Lenz J; Steinfeld AD; Nixon DF
    AIDS Res Hum Retroviruses; 2006 Jan; 22(1):52-6. PubMed ID: 16438646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multidimensional Clusters of CD4+ T Cell Dysfunction Are Primarily Associated with the CD4/CD8 Ratio in Chronic HIV Infection.
    Frederiksen J; Buggert M; Noyan K; Nowak P; Sönnerborg A; Lund O; Karlsson AC
    PLoS One; 2015; 10(9):e0137635. PubMed ID: 26402620
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of human endogenous retrovirus K and W in babies.
    Nali LH; Oliveira AC; Alves DO; Caleiro GS; Nunes CF; Gerhardt D; Succi RC; Romano CM; Machado DM
    Arch Virol; 2017 Mar; 162(3):857-861. PubMed ID: 27885560
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human endogenous retrovirus K Gag coassembles with HIV-1 Gag and reduces the release efficiency and infectivity of HIV-1.
    Monde K; Contreras-Galindo R; Kaplan MH; Markovitz DM; Ono A
    J Virol; 2012 Oct; 86(20):11194-208. PubMed ID: 22855497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potential role for HIV-specific CD38-/HLA-DR+ CD8+ T cells in viral suppression and cytotoxicity in HIV controllers.
    Hua S; Lécuroux C; Sáez-Cirión A; Pancino G; Girault I; Versmisse P; Boufassa F; Taulera O; Sinet M; Lambotte O; Venet A
    PLoS One; 2014; 9(7):e101920. PubMed ID: 25000587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A steady state of CD4+ T cell memory maturation and activation is established during primary subtype C HIV-1 infection.
    Maenetje P; Riou C; Casazza JP; Ambrozak D; Hill B; Gray G; Koup RA; de Bruyn G; Gray CM
    J Immunol; 2010 May; 184(9):4926-35. PubMed ID: 20363974
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA.
    Kaufmann GR; Zaunders JJ; Cunningham P; Cooper DA
    AIDS Res Hum Retroviruses; 1999 Jul; 15(11):963-72. PubMed ID: 10445808
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy.
    Khoury G; Fromentin R; Solomon A; Hartogensis W; Killian M; Hoh R; Somsouk M; Hunt PW; Girling V; Sinclair E; Bacchetti P; Anderson JL; Hecht FM; Deeks SG; Cameron PU; Chomont N; Lewin SR
    J Infect Dis; 2017 Mar; 215(6):911-919. PubMed ID: 28453847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.